To further understand the molecular mechanism of irisin as a candidate for the prevention and treatment of obesity and related metabolic disorders, we examined whether GST-irisin could promote its autocrine function in mature 3T3-L1 adipocytes. Here, FNDC5 is linked to obesity disorder.